{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:18:46Z","timestamp":1778887126247,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41375-025-02736-x","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:59:39Z","timestamp":1756209579000},"page":"2779-2788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-5811","authenticated-orcid":false,"given":"Simone","family":"Zocchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Trichet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0541-0423","authenticated-orcid":false,"given":"Paloma","family":"Guernalec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9976-8290","authenticated-orcid":false,"given":"Manal","family":"Agdada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3723-429X","authenticated-orcid":false,"given":"Ana","family":"Alonso Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0535-9287","authenticated-orcid":false,"given":"Vincent","family":"Ogor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9872-6263","authenticated-orcid":false,"given":"Caroline","family":"Choisy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6266-1994","authenticated-orcid":false,"given":"Carine","family":"Vias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4424-8736","authenticated-orcid":false,"given":"Xavier","family":"Sabat\u00e9-Cadenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-9536","authenticated-orcid":false,"given":"Jean-Christophe","family":"Bories","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-3514","authenticated-orcid":false,"given":"Michele","family":"Goodhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-4700","authenticated-orcid":false,"given":"Alena","family":"Shkumatava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7422-7986","authenticated-orcid":false,"given":"David","family":"Garrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2736_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","volume":"10","author":"F Malard","year":"2024","unstructured":"Malard F, Neri P, Bahlis NJ, Terpos E, Moukalled N, Hungria VTM, et al. Multiple myeloma. Nat Rev Dis Prim. 2024;10:45.","journal-title":"Nat Rev Dis Prim"},{"key":"2736_CR2","unstructured":"NIH National Cancer Institute. Cancer stat facts: myeloma [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html]."},{"key":"2736_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086\u2013107.","journal-title":"Am J Hematol"},{"key":"2736_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0065-8","volume":"8","author":"P Ravi","year":"2018","unstructured":"Ravi P, Kumar SK, Cerhan JR, Maurer MJ, Dingli D, Ansell SM, et al. Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies. Blood Cancer J. 2018;8:26.","journal-title":"Blood Cancer J"},{"key":"2736_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.clml.2022.01.011","volume":"22","author":"MA Dimopoulos","year":"2022","unstructured":"Dimopoulos MA, Richardson P, Lonial S. Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022;22:460\u201373.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2736_CR6","doi-asserted-by":"crossref","unstructured":"Zocchi S, David A, Goodhardt M, Garrick D. Applications of noncoding ribonucleic acids in multiple myeloma patients. In: Gupta SC, Challagundla KB, editors. Clinical Applications of Non-Coding RNAs in Cancer: Academic Press; 2022. p. 97-140.","DOI":"10.1016\/B978-0-12-824550-7.00005-9"},{"key":"2736_CR7","doi-asserted-by":"crossref","unstructured":"Morelli E, Gulla A, Rocca R, Federico C, Raimondi L, Malvestiti S, et al. The non-coding RNA landscape of plasma cell Dyscrasias. Cancers. 2020;12.","DOI":"10.3390\/cancers12020320"},{"key":"2736_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nature Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"2736_CR9","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Molecular Cell. 2022;82:2252\u201366.","journal-title":"Molecular Cell"},{"key":"2736_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41375-021-01147-y","volume":"35","author":"A Carrasco-Leon","year":"2021","unstructured":"Carrasco-Leon A, Ezponda T, Meydan C, Valcarcel LV, Ordonez R, Kulis M, et al. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia. 2021;35:1438\u201350.","journal-title":"Leukemia"},{"key":"2736_CR11","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41375-018-0116-y","volume":"32","author":"MK Samur","year":"2018","unstructured":"Samur MK, Minvielle S, Gulla A, Fulciniti M, Cleynen A, Aktas Samur A, et al. Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma. Leukemia. 2018;32:2626\u201335.","journal-title":"Leukemia"},{"key":"2736_CR12","doi-asserted-by":"crossref","unstructured":"Ronchetti D, Agnelli L, Pietrelli A, Todoerti K, Manzoni M, Taiana E, et al. A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma. Sci Rep. 2018;8.","DOI":"10.1038\/s41598-018-24701-8"},{"key":"2736_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3813546","volume":"2020","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Liu Z, Li D, Liao Q, Li J. Identification and validation of a potential prognostic 7-lncRNA signature for predicting survival in patients with multiple myeloma. Biomed Res Int. 2020;2020:3813546.","journal-title":"Biomed Res Int"},{"key":"2736_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3727\/096504017X14886679715637","volume":"25","author":"YB Meng","year":"2017","unstructured":"Meng YB, He X, Huang YF, Wu QN, Zhou YC, Hao DJ. Long noncoding RNA CRNDE promotes multiple myeloma cell growth by suppressing miR-451. Oncol Res. 2017;25:1207\u201314.","journal-title":"Oncol Res"},{"key":"2736_CR15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41375-020-01034-y","volume":"35","author":"A David","year":"2021","unstructured":"David A, Zocchi S, Talbot A, Choisy C, Ohnona A, Lion J, et al. The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling. Leukemia. 2021;35:1710\u201321.","journal-title":"Leukemia"},{"key":"2736_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.omtn.2022.03.006","volume":"28","author":"X Ma","year":"2022","unstructured":"Ma X, Jin W, Zhao C, Wang X, Wang K. CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies. Mol Ther Nucleic Acids. 2022;28:190\u2013201.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2736_CR17","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.molcel.2025.03.006","volume":"85","author":"JS Lee","year":"2025","unstructured":"Lee JS, Dan T, Zhang H, Cheng Y, Rehfeld F, Brugarolas J, et al. An ultraconserved snoRNA-like element in long noncoding RNA CRNDE promotes ribosome biogenesis and cell proliferation. Molecular Cell. 2025;85:1543\u201360.e10.","journal-title":"Molecular Cell"},{"key":"2736_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nrm.2016.126","volume":"17","author":"JM Engreitz","year":"2016","unstructured":"Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nature Rev Mol Cell Biol. 2016;17:756\u201370.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"2736_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41388-019-1037-6","volume":"39","author":"Y Xie","year":"2020","unstructured":"Xie Y, Liu J, Jiang H, Wang J, Li X, Wang J, et al. Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma. Oncogene. 2020;39:922\u201334.","journal-title":"Oncogene"},{"key":"2736_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3324\/haematol.2009.015495","volume":"95","author":"EM Ocio","year":"2010","unstructured":"Ocio EM, Vilanova D, Atadja P, Maiso P, Crusoe E, Fernandez-Lazaro D, et al. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica. 2010;95:794\u2013803.","journal-title":"Haematologica"},{"key":"2736_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13235-w","volume":"10","author":"A Graindorge","year":"2019","unstructured":"Graindorge A, Pinheiro I, Nawrocka A, Mallory AC, Tsvetkov P, Gil N, et al. In-cell identification and measurement of RNA-protein interactions. Nature Commun. 2019;10:5317.","journal-title":"Nature Commun"},{"key":"2736_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fgene.2012.00270","volume":"3","author":"BC Ellis","year":"2012","unstructured":"Ellis BC, Molloy PL, Graham LD. CRNDE: A long non-coding RNA involved in CanceR, Neurobiology, and DEvelopment. Frontiers Genet. 2012;3:270.","journal-title":"Frontiers Genet"},{"key":"2736_CR23","first-page":"1437","volume":"9","author":"T Liu","year":"2016","unstructured":"Liu T, Zhang X, Yang YM, Du LT, Wang CX. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression. Onco Targets Ther. 2016;9:1437\u201348.","journal-title":"Onco Targets Ther"},{"key":"2736_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.bbamcr.2013.10.016","volume":"1843","author":"BC Ellis","year":"2014","unstructured":"Ellis BC, Graham LD, Molloy PL. CRNDE, a long non-coding RNA responsive to insulin\/IGF signaling, regulates genes involved in central metabolism. Biochimica et biophys Acta. 2014;1843:372\u201386.","journal-title":"Biochimica et biophys Acta"},{"key":"2736_CR25","doi-asserted-by":"publisher","first-page":"bau012","DOI":"10.1093\/database\/bau012","volume":"2014","author":"JX Binder","year":"2014","unstructured":"Binder JX, Pletscher-Frankild S, Tsafou K, Stolte C, O\u2019Donoghue SI, Schneider R, et al. COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database. 2014;2014:bau012.","journal-title":"Database"},{"key":"2736_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129952","volume":"1865","author":"LM Garcia-Peterson","year":"2021","unstructured":"Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj. 2021;1865:129952.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2736_CR27","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.4161\/cc.25251","volume":"12","author":"MY Murray","year":"2013","unstructured":"Murray MY, Rushworth SA, Zaitseva L, Bowles KM, Macewan DJ. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression. Cell Cycle. 2013;12:2144\u201353.","journal-title":"Cell Cycle"},{"key":"2736_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3892\/ol.2021.12567","volume":"21","author":"B Lu","year":"2021","unstructured":"Lu B, Zhang D, Wang X, Lin D, Chen Y, Xu X. Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells. Oncol Lett. 2021;21:306.","journal-title":"Oncol Lett"},{"key":"2736_CR29","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41388-020-1298-0","volume":"39","author":"L Yu","year":"2020","unstructured":"Yu L, Dong L, Li H, Liu Z, Luo Z, Duan G, et al. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis. Oncogene. 2020;39:4450\u201364.","journal-title":"Oncogene"},{"key":"2736_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1541-7786.MCR-22-0825","volume":"21","author":"R Zhao","year":"2023","unstructured":"Zhao R, Liu Y, Wang Z, Zhang J, Zhang W, Zhou X, et al. UBE2C-mediated autophagy inhibition via ubiquitination of SIRT1 contributes to endometrial cancer progression. Mol Cancer Res. 2023;21:564\u201377.","journal-title":"Mol Cancer Res"},{"key":"2736_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52201-z","volume":"15","author":"M Ma","year":"2024","unstructured":"Ma M, Yi L, Pei Y, Zhang Q, Tong C, Zhao M, et al. USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling. Nat Commun. 2024;15:7856.","journal-title":"Nat Commun"},{"key":"2736_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1535-7163.MCT-09-0971","volume":"9","author":"B Peck","year":"2010","unstructured":"Peck B, Chen CY, Ho KK, Di Fruscia P, Myatt SS, Coombes RC, et al. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther. 2010;9:844\u201355.","journal-title":"Mol Cancer Ther"},{"key":"2736_CR33","doi-asserted-by":"publisher","first-page":"e65718","DOI":"10.1371\/journal.pone.0065718","volume":"8","author":"S Coni","year":"2013","unstructured":"Coni S, Antonucci L, D\u2019Amico D, Di Magno L, Infante P, De Smaele E, et al. Gli2 acetylation at lysine 757 regulates hedgehog-dependent transcriptional output by preventing its promoter occupancy. PloS One. 2013;8:e65718.","journal-title":"PloS One"},{"key":"2736_CR34","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1042\/BCJ20200335","volume":"477","author":"EJ Tolosa","year":"2020","unstructured":"Tolosa EJ, Fernandez-Barrena MG, Iguchi E, McCleary-Wheeler AL, Carr RM, Almada LL, et al. GLI1\/GLI2 functional interplay is required to control Hedgehog\/GLI targets gene expression. Biochem J. 2020;477:3131\u201345.","journal-title":"Biochem J"},{"key":"2736_CR35","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1074\/jbc.RA120.013268","volume":"295","author":"SL Safgren","year":"2020","unstructured":"Safgren SL, Olson RLO, Vrabel AM, Almada LL, Marks DL, Hernandez-Alvarado N, et al. The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements. Journal Biol Chem. 2020;295:8725\u201335.","journal-title":"Journal Biol Chem"},{"key":"2736_CR36","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41588-024-01853-0","volume":"56","author":"S Skerget","year":"2024","unstructured":"Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, et al. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet. 2024;56:1878\u201389.","journal-title":"Nat Genet"},{"key":"2736_CR37","doi-asserted-by":"crossref","unstructured":"Kotulak-Chrzaszcz A, Rybarczyk A, Klacz J, Matuszewski M, Kmiec Z, Wierzbicki PM. Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma. Int J Mol Med. 2022;49:58.","DOI":"10.3892\/ijmm.2022.5114"},{"key":"2736_CR38","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1042\/CS20180845","volume":"133","author":"M Katoh","year":"2019","unstructured":"Katoh M. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers. Clin Sci. 2019;133:953\u201370.","journal-title":"Clin Sci"},{"key":"2736_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/leu.2015.334","volume":"30","author":"C Gu","year":"2016","unstructured":"Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, et al. FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia. 2016;30:873\u201382.","journal-title":"Leukemia"},{"key":"2736_CR40","doi-asserted-by":"crossref","unstructured":"Ria R, Melaccio A, Racanelli V, Vacca A. Anti-VEGF drugs in the treatment of multiple myeloma patients. J Clin Med. 2020;9:1765.","DOI":"10.3390\/jcm9061765"},{"key":"2736_CR41","doi-asserted-by":"crossref","unstructured":"Sari IN, Phi LTH, Jun N, Wijaya YT, Lee S, Kwon HY. Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells. Cells. 2018;7:208.","DOI":"10.3390\/cells7110208"},{"key":"2736_CR42","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA. 2007;104:4048\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2736_CR43","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1158\/1535-7163.MCT-13-0997","volume":"13","author":"JR Agarwal","year":"2014","unstructured":"Agarwal JR, Wang Q, Tanno T, Rasheed Z, Merchant A, Ghosh N, et al. Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma. Mol Cancer Ther. 2014;13:1873\u201381.","journal-title":"Mol Cancer Ther"},{"key":"2736_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ijc.31041","volume":"142","author":"B Tang","year":"2018","unstructured":"Tang B, Xu A, Xu J, Huang H, Chen L, Su Y, et al. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. Int J Cancer. 2018;142:109\u201320.","journal-title":"Int J Cancer"},{"key":"2736_CR45","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1002\/jcb.26885","volume":"119","author":"N Jin","year":"2018","unstructured":"Jin N, Zhu X, Cheng F, Zhang L. Disulfiram\/copper targets stem cell-like ALDH(+) population of multiple myeloma by inhibition of ALDH1A1 and Hedgehog pathway. J Cell Biochem. 2018;119:6882\u201393.","journal-title":"J Cell Biochem"},{"key":"2736_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","volume":"68","author":"W Matsui","year":"2008","unstructured":"Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008;68:190\u20137.","journal-title":"Cancer Res"},{"key":"2736_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.08.005","volume":"277","author":"N Ghosh","year":"2009","unstructured":"Ghosh N, Matsui W. Cancer stem cells in multiple myeloma. Cancer Lett. 2009;277:1\u20137.","journal-title":"Cancer Lett"},{"key":"2736_CR48","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.18632\/oncotarget.6920","volume":"7","author":"H Tomita","year":"2016","unstructured":"Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7:11018\u201332.","journal-title":"Oncotarget"},{"key":"2736_CR49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s11010-020-04047-4","volume":"476","author":"C Shi","year":"2021","unstructured":"Shi C, Zheng W, Wang J. lncRNA-CRNDE regulates BMSC chondrogenic differentiation and promotes cartilage repair in osteoarthritis through SIRT1\/SOX9. Mol Cell Biochem. 2021;476:1881\u201390.","journal-title":"Mol Cell Biochem"},{"key":"2736_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.15430\/JCP.2022.27.3.157","volume":"27","author":"YH Lee","year":"2022","unstructured":"Lee YH, Kim SJ, Surh YJ. Role of post-translational modification of silent mating type information regulator 2 Homolog 1 in cancer and other disorders. J Cancer Prev. 2022;27:157\u201369.","journal-title":"J Cancer Prev"},{"key":"2736_CR51","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/onc.2016.521","volume":"36","author":"H Xiong","year":"2017","unstructured":"Xiong H, Ni Z, He J, Jiang S, Li X, He J, et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 2017;36:3528\u201340.","journal-title":"Oncogene"},{"key":"2736_CR52","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/15384101.2020.1743915","volume":"19","author":"K Li","year":"2020","unstructured":"Li K, Cui M, Zhang K, Wang G, Zhai S. LncRNA CRNDE affects the proliferation and apoptosis of vascular smooth muscle cells in abdominal aortic aneurysms by regulating the expression of Smad3 by Bcl-3. Cell Cycle. 2020;19:1036\u201347.","journal-title":"Cell Cycle"},{"key":"2736_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06137-9","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zou R, Gu Q, Wang X, Zhang J, Ma R, et al. CRNDE-mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer. Cell Death Dis. 2023;14:611.","journal-title":"Cell Death Dis"},{"key":"2736_CR54","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1080\/08820139.2021.1989461","volume":"51","author":"M Shen","year":"2022","unstructured":"Shen M, Pan X, Gao Y, Ye H, Zhang J, Chen Y, et al. LncRNA CRNDE exacerbates IgA nephropathy progression by promoting NLRP3 inflammasome activation in macrophages.Immunol Invest. 2022;51:1515\u201327.","journal-title":"Immunol Invest"},{"key":"2736_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/08916934.2021.1913580","volume":"54","author":"X Zhu","year":"2021","unstructured":"Zhu X, Li S, Huang C, Huang G, Xu J. LncRNA CRNDE inhibits cardiomyocytes apoptosis by YAP1 in myocardial ischaemia\/reperfusion injury. Autoimmunity. 2021;54:204\u201312.","journal-title":"Autoimmunity"},{"key":"2736_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03376-y","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun J, Jia H, Bao X, Wu Y, Zhu T, Li R, et al. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer. Cell Death Dis. 2021;12:123.","journal-title":"Cell Death Dis"},{"key":"2736_CR57","doi-asserted-by":"crossref","unstructured":"Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochimica Biophys Acta. 2010;1804:1666\u201375.","DOI":"10.1016\/j.bbapap.2009.10.022"},{"key":"2736_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7:402.","journal-title":"Signal Transduct Target Ther"},{"key":"2736_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2019.00038","volume":"10","author":"V Carafa","year":"2019","unstructured":"Carafa V, Altucci L, Nebbioso A. Dual tumor suppressor and tumor promoter action of Sirtuins in determining malignant phenotype. Front Pharm. 2019;10:38.","journal-title":"Front Pharm"},{"key":"2736_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.7150\/ijbs.5.147","volume":"5","author":"CX Deng","year":"2009","unstructured":"Deng CX. SIRT1, is it a tumor promoter or tumor suppressor?. Int J Biol Sci. 2009;5:147\u201352.","journal-title":"Int J Biol Sci"},{"key":"2736_CR61","doi-asserted-by":"crossref","unstructured":"Goes JVC, Carvalho LG, de Oliveira RTG, Melo MML, Novaes LAC, Moreno DA, et al. Role of Sirtuins in the pathobiology of onco-hematological diseases: A PROSPERO-registered study and in silico analysis. Cancers. 2022;14:4611.","DOI":"10.3390\/cancers14194611"},{"key":"2736_CR62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2141.2011.08888.x","volume":"155","author":"D Chauhan","year":"2011","unstructured":"Chauhan D, Bandi M, Singh AV, Ray A, Raje N, Richardson P, et al. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells. Br J Haematol. 2011;155:588\u201398.","journal-title":"Br J Haematol"},{"key":"2736_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.exphem.2011.06.007","volume":"39","author":"FM Wang","year":"2011","unstructured":"Wang FM, Galson DL, Roodman GD, Ouyang H. Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells. Exp Hematol. 2011;39:999\u20131006.","journal-title":"Exp Hematol"},{"key":"2736_CR64","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1158\/0008-5472.CAN-15-2934","volume":"76","author":"D Perumal","year":"2016","unstructured":"Perumal D, Kuo PY, Leshchenko VV, Jiang Z, Divakar SK, Cho HJ, et al. Dual Targeting of CDK4 and ARK5 using a novel kinase inhibitor ON123300 exerts potent anticancer activity against multiple myeloma. Cancer Res. 2016;76:1225\u201336.","journal-title":"Cancer Res"},{"key":"2736_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0560-6","volume":"16","author":"M Lizio","year":"2015","unstructured":"Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S, et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 2015;16:22.","journal-title":"Genome Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02736-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02736-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02736-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:04:18Z","timestamp":1762337058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02736-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02736-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Animal protocols were compliant with regulations of the ethical committee Paris-Nord\/N\u00b0121 (Approval #APAFIS#19755-2019031316181939v2). This study includes analysis of previously published transcriptomic datasets from TCGA and CoMMpass cohorts, containing samples collected according to the declaration of Helsinki [\n                      \n                      ] and as described at\n                      \n                      . No human samples were collected for the current study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}